The American Cancer Society estimates that between 2% and 5% of patient who have been diagnosed with metastatic cancer however the primary site can’t be located. This session will discuss how clinical decisions are made when a primary cancer site cannot be diagnosed.
The learner will be able to state three reasons why a primary site can’t be located.
The learner will be able to state the largest pathological type of cancer from an unknown primary
The learner will be able to state the treatment options for cancers with an unknown primary.
Professor of Pathology and Laboratory Medicine,
Hospital at the University of Pennsylvania
You must be logged in and own this session in order to